We are a unique life sciences platform with an innovative business model in the European panorama. The main goals are the participation of academic spinoffs and commercialization of cutting edge technologies with the purpose of delivering them to the major markets. Our commitment is to provide government and people with the most effective care and enhanced quality of life by providing cost-effective, quality-oriented and market-focused solutions.
- HLG Winter meeting: Cube-Labs will take part with Renato Del Grosso. 5 December 2019
- Cube-Labs attending the second meeting of the Erasmus+ BIO-ALL project. 27 November 2019
- Chris Hentschel new CSO at Cube-Labs. 25 November 2019